Journal of Materials Science: Materials in Medicine

, Volume 17, Issue 12, pp 1227–1236 | Cite as

Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer

  • S. Kalachandra
  • T. Takamata
  • D. M. Lin
  • E. A. Snyder
  • J. Webster-Cyriaque


The use of polymer based drug delivery systems in dentistry is a relatively new area of research with the exception of the inhibition of secondary caries by the release of fluoride ions from polyalkenoate cements and their predecessors silicate cements. The present study was to test on orally biocompatible material, ethylene vinyl acetate copolymer (EVA), for release of antiviral drugs at oral therapeutic levels over extended periods of time. We also determined their stability during film casting and release. Materials studied include gancyclovir (GCY), acyclovir (ACY), dichloromethane (DCM), and ethylene vinyl acetate (EVA). The square films (3 × 3 × 0.1 cm) were prepared from the dry sheet obtained by solvent evaporation of polymer casting solutions. These solutions were made of EVA and the drug (40:1) in 70 ml of dichloromethane at 38C. Then drug release characteristics from the drug loaded films were examined at 37C for a minimum of 14 days in 10 ml medium (ddwater) replaced daily. Kinetics of drug release were followed by spectral measurements using previously determined λmax values (GCY = 250 nm; ACY = 253 nm). A minimum of three samples was tested and reproducible results were obtained. Drug stability (ACY) during film casting and its release was determined using 1H NMR spectrometer (Bruker DRX-500 and 400). Rate of drug release was determined from the part of the curve (rate vs. time) after the onset of the “burst.” Although GCY has a larger molecular weight (255) than ACY (225), GCY exhibited about three times higher rate of release than ACY. This difference in rate values may be explained due to its relatively greater solubility in EVA, facilitating faster diffusion of the molecules through the channels present in EVA. This is consistent with the observation that the rate at which drug molecules diffuse through the channels of the polymer, can be increased by decreasing the molecular weight. In the case of ACY, the molecules may be undergoing molecular associations, perhaps dimerization or trimerization in addition to its lower solubility in EVA. The diffusion of ACY tends to be slower under these circumstances compared to GCY resulting in lower rate value than in the case of GCY. Biological studies revealed that ACY exhibited a remarkable decrease in a number of viral organisms present in virus infected cell culture system using real-time polymerase chain reaction (RT-PCR). NMR analysis indicates that the chemical structure of the drug remains stable during film casting process and release.


Drug Release Acyclovir B958 Cell Ethylene Vinyl Acetate Ethylene Vinyl Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    S. FREEMAN and J. M. GARDINER, Mol. Biotechnol. 5 (1996) 125.Google Scholar
  2. 2.
    M. P. PATEL, G. J. PEARSON, M. BRADEN and M. A. MIRZA, Biomater. 19 (1998) 1911.CrossRefGoogle Scholar
  3. 3.
    P. D. RIGGS, M. BRADEN and M. P. PATEL, Biomater. 21 (2000) 245.CrossRefGoogle Scholar
  4. 4.
    J. AHRENDS and J. RUBEN, Quintessence International 9 (1988) 513.Google Scholar
  5. 5.
    M. ROTHWELL, H. M. ANSTICE and G. J. PEARSON, J. Dent. 26 (1998) 591.CrossRefGoogle Scholar
  6. 6.
    S. KALACHANDRA, D. M. LIN and S. OFFENBACHER, J. Mater. Sci: Mater. Med. 13 (2002) 53.CrossRefGoogle Scholar
  7. 7.
    D. M. LIN, S. KALACHANDRA, J. VALIYAPARAMBIL and S. OFFENBACHER, Dent. Mater. 19 (2003) 589.CrossRefGoogle Scholar
  8. 8.
    L. GRADOVILLE, D. KWA, A. EL-GUINDY and G. MILLER, J. Virol. 76 (2002) 5612.CrossRefGoogle Scholar
  9. 9.
    G. MILLER, L. HESTON, E. GROGAN, L. GRADOVILLE, M. RIGSBY, R. SUN, D. SHEDD, V. M. KUSHNARYOV, S. GROSSBERG and Y. CHANG, J. Virol. 71 (1997) 314.Google Scholar
  10. 10.
    R. LANGER and J. FOLKMAN, Nature 263 (1976) 797.CrossRefGoogle Scholar
  11. 11.
    X. HAUNG and S. B. CHRISTOPHER, J. Control Release 73(2001) 121.CrossRefGoogle Scholar
  12. 12.
    Y. TABATA, S. GUTTA and R. LANGER, Pharm. Res. 48 (1993) 487.CrossRefGoogle Scholar
  13. 13.
    J. HELLER, Biomater. 11 (1990) 659.CrossRefGoogle Scholar
  14. 14.
    Y. OGAWA, H. OKADA, M. YAMAMOTO and T. SHIMAMOTO, Chem. Pharm. Bull. (Japan) 36 (1988) 2576.Google Scholar
  15. 15.
    K. J. LAIDLER, in “Chemical Kinetics” (McGraw-Hill Inc., New York, 1965) p. 50.Google Scholar
  16. 16.
    S. GLASSTONE, in “The Elements of Physical Chemistry” (D. Van Nostrand Company, Inc., New York, 1946) p. 606.Google Scholar
  17. 17.
    W. M. SALTZMAN and R. LANGER, Biophys J. 55 (1989) 163.CrossRefGoogle Scholar
  18. 18.
    M. J. Mahoney and W. M. SALTZMAN, J. Pharm. Sci. 85 (1996) 1276.CrossRefGoogle Scholar
  19. 19.
    A. H. SHOJAE, Z. SEN-LIN and X. LI, J. Pharm. Pharmaceut. Sci. 1 (1998) 66.Google Scholar

Copyright information

© Springer Science + Business Media, LLC 2006

Authors and Affiliations

  • S. Kalachandra
    • 1
  • T. Takamata
    • 2
  • D. M. Lin
    • 1
  • E. A. Snyder
    • 1
  • J. Webster-Cyriaque
    • 1
  1. 1.Dental Research CenterUniversity of North CarolinaChapel HillUSA
  2. 2.Matsumoto Dental UniversityNaganoJapan

Personalised recommendations